HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Effectiveness of acetylspiramycin for Mycoplasma pneumonia in children (author's transl)].

Abstract
The clinical efficacy and safety of acetylspiramycin for Mycoplasma pneumonia in children were studied at a dose level of 50 mg/kg/day q.i.d. and the following results were obtained. Acetylspiramycin showed effect in 24 patients out of 25 (96.0%). The level of transminase was increased in 3 cases on admission. One of them was an uneffective case, and eruption was seen after administrating the drug. Diarrhea and poor appetite were observed in one case as side effects, and they were controlled easily. It may be concluded from these results acetylspiramycin was relatively free from side effects and considered to be useful for Mycoplasma pneumonia.
AuthorsK Iguchi, T Ninomiya, H Kamiya, T Yoshizumi, M Ukyo, K Kobayashi, H Nishi, T Iwasa
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 34 Issue 7 Pg. 1071-7 (Jul 1981) ISSN: 0368-2781 [Print] Japan
PMID7321185 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Leucomycins
  • acetylspiramycin
  • Spiramycin
Topics
  • Age Factors
  • Anti-Bacterial Agents (adverse effects, therapeutic use)
  • Child
  • Child, Preschool
  • Drug Evaluation
  • Female
  • Humans
  • Leucomycins (adverse effects, therapeutic use)
  • Male
  • Pneumonia, Mycoplasma (drug therapy)
  • Spiramycin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: